Bilian Jin
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
Papers in
-
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 7
- Circular RNAs in diseases 4
- Cancer-related gene regulation 4
- DNA Repair Mechanisms 3
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Co-authors
- Keith D. Robertson (5 shared papers)C. Robert Fields (2 shared papers)Amber L. Delmas (2 shared papers)Eric W.‐F. Lam (6 shared papers)Jawaharlal M. Patel (3 shared papers)Edward R. Block (3 shared papers)Quentin Liu (4 shared papers)Chen Liu (2 shared papers)
- Journals
- Oncotarget (2 papers)Oncogene (2 papers)BMC Genomics (1 paper)Human Molecular Genetics (1 paper)Science Advances (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bilian Jin
31 papers receiving 2.4k citations
Bilian Jin's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 498
- Molecular Biology 1.6k
- Hepatology 106
- Cell Biology 182
- Oncology 267
Countries citing papers authored by Bilian Jin
This map shows the geographic impact of Bilian Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilian Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilian Jin more than expected).
Fields of papers citing papers by Bilian Jin
This network shows the impact of papers produced by Bilian Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilian Jin. The network helps show where Bilian Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Bilian Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA Methylation: Superior or Subordinate in the Epigenetic Hierarchy? Hit paper breakdown → | 2011 | 565 |
| 2 | 2012 | 377 | |
| 3 | 2016 | 223 | |
| 4 | 2007 | 181 | |
| 5 | 2020 | 159 | |
| 6 | 1997 | 147 | |
| 7 | 2009 | 90 | |
| 8 | 2004 | 86 | |
| 9 | 2012 | 81 | |
| 10 | 2011 | 69 | |
| 11 | 2008 | 40 | |
| 12 | TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells. | 1989 | 40 |
| 13 | 2013 | 33 | |
| 14 | 2017 | 33 | |
| 15 | 2011 | 31 | |
| 16 | 2022 | 30 | |
| 17 | 2016 | 30 | |
| 18 | 2021 | 28 | |
| 19 | 2015 | 27 | |
| 20 | 2013 | 22 |
About Bilian Jin
Bilian Jin is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Hematology, having authored 33 papers that have together received 2.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers), Cancer-related gene regulation (4 papers), MicroRNA in disease regulation (4 papers), DNA Repair Mechanisms (3 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Cancer Research (498 citations), Molecular Biology (1.6k citations), Hepatology (106 citations), Cell Biology (182 citations) and Oncology (267 citations). Bilian Jin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Keith D. Robertson, C. Robert Fields, Amber L. Delmas, Eric W.‐F. Lam, Jawaharlal M. Patel, Edward R. Block, Quentin Liu, Chen Liu, Liuzhe Li and Jianliang Zhang. Their work appears in journals such as Oncotarget, Oncogene, BMC Genomics, Human Molecular Genetics and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.